Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 22 of 114

  1. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Adenovirus Infection

    phase 3 small molecule completed

    1 trial

  2. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Double-stranded DNA Virus

    phase 3 small molecule completed

    1 trial

  3. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    CMV

    phase 3 small molecule completed

    1 trial

  4. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Cytomegalovirus Disease

    phase 3 small molecule terminated

    2 trials

  5. Brivaracetam

    UCB Pharma

    Epilepsy

    phase 3 small molecule completed

    1 trial

  6. BuS2020

    The George Institute

    Bronchopulmonary dysplasia, Preterm newborns ≤32 weeks of gestational age.

    phase 3 small molecule active

    1 trial

  7. Budesonide

    Bausch + Lomb Ireland Limited

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial

  8. Budesonide

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  9. Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  10. Budesonide oral suspension

    Takeda

    Eosinophilic Esophagitis (EoE)

    phase 3 small molecule terminated

    1 trial

  11. Budesonide/Formoterol SPIROMAX®

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  12. Budesonide/Formoterol fumarate dihydrate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule active

    1 trial

  13. Budesonide/formoterol Turbuhaler

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  14. Bufei Yishen granule

    Henan University of Traditional Chinese Medicine

    Chronic Obstructive Pulmonary Disease

    phase 3 small molecule active

    1 trial

  15. Bupivacaine

    United Therapeutics Europe Ltd

    Postoperative Pain

    phase 3 small molecule active

    1 trial

  16. Bupivacaine

    Pacira Ireland Limited

    Malignant Neoplasms of Female Genital Organs

    phase 3 small molecule terminated

    1 trial

  17. Bupivacaine HCl

    Pacira Ireland Limited

    Hemorrhoids

    phase 3 small molecule completed

    1 trial

  18. Bupivacaine HCl

    Pacira Ireland Limited

    Postoperative Pain

    phase 3 small molecule completed

    3 trials

  19. Bupivacaine Liposome Injection

    United Therapeutics Europe Ltd

    Osteoarthritis

    phase 3 small molecule terminated

    1 trial

  20. Bupivacaine liposome

    Pacira Ireland Limited

    Dental Pain

    phase 3 small molecule completed

    1 trial

  21. Bupivacaine liposome injectable suspension 266 mg

    Pacira Ireland Limited

    Bunionectomy

    phase 3 small molecule completed

    1 trial

  22. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 3 small molecule active

    1 trial

  23. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 3 small molecule completed

    5 trials

  24. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 3 small molecule completed

    2 trials

  25. Buprenorphine + Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 3 small molecule completed

    1 trial

  26. Buprenorphine +OTP

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Addiction

    phase 3 small molecule completed

    1 trial

  27. Buprenorphine Injection

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 3 small molecule completed

    1 trial

  28. Buprenorphine Transdermal System

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Disease (or Disorder); Intervertebral Disc, With Myelopathy (Manifestation)

    phase 3 small molecule completed

    1 trial

  29. Buprenorphine/Naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 small molecule terminated

    1 trial

  30. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 3 small molecule terminated

    6 trials

  31. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 3 small molecule completed

    2 trials

  32. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 3 small molecule completed

    1 trial

  33. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 3 small molecule active

    3 trials

  34. Burosumab

    Ultragenyx UK Limited

    Hypophosphatemia

    phase 3 mab completed

    1 trial

  35. Busulfan (BU)

    The First People's Hospital of Lianyungang

    Primary Central Nervous System Lymphoma

    phase 3 small molecule active

    1 trial

  36. Butylphthalide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Restenosis

    phase 3 small molecule completed

    1 trial

  37. Butylphthalide soft capsule

    NovaBridge Biosciences

    Vascular Dementia

    phase 3 small molecule active

    1 trial

  38. C0251010

    Pfizer Australia Pty Ltd

    Idiopathic Inflammatory Myopathy (including dermatomyositis or polymyositis)

    phase 3 small molecule active

    1 trial

  39. C0371017

    Pfizer Australia Pty Ltd

    hemophilia A, severe to moderately severe hemophilia B (FIX:C ≤ 2%)

    phase 3 small molecule active

    1 trial

  40. C1 esterase inhibitor [human] (C1INH-nf)

    Takeda

    Hereditary Angioedema

    phase 3 mab completed

    5 trials

  41. C1 esterase inhibitor [human] liquid

    Takeda

    Hereditary Angioedema (HAE)

    phase 3 small molecule completed

    1 trial

  42. C1071005

    Pfizer Australia Pty Ltd

    MULTIPLE MYELOMA

    phase 3 small molecule active

    1 trial

  43. C1071006

    Pfizer Australia Pty Ltd

    Multiple myeloma

    phase 3 small molecule active

    1 trial

  44. C1071007

    Pfizer Australia Pty Ltd

    Multiple Myeloma

    phase 3 small molecule active

    1 trial

  45. C1071032

    Pfizer Australia Pty Ltd

    Relapsed/Refractory Multiple Myeloma

    phase 3 small molecule active

    1 trial

  46. C1091009

    Pfizer Australia Pty Ltd

    Group B streptococcus (GBS) disease

    phase 3 small molecule active

    1 trial

  47. C16-40

    The George Institute

    Unresectable locally advanced and/or metastatic soft-tissue sarcoma

    phase 3 small molecule active

    1 trial

  48. C2321003

    Pfizer Australia Pty Ltd

    METASTATIC CASTRATION RESISTANT PROSTATE CANCER

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.